Merchavia Holdings and Investments Ltd (TASE: MRHL)
Health Care · Health Care Equipment & Supplies · IL
₪1.66
-5.72% today · +94.2% 1Y
Merchavia Holdings and Investments Ltd (TASE: MRHL) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $11.66M and employs 1 people.
Over the last twelve months the share price has gained 94.2%, trading between 0.78 and 3.30.
Tweenvest scores Merchavia Holdings and Investments Ltd across four factors: quality 26/100, value 87/100. Its strongest factor is value.
MRHL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.66M
- Revenue (TTM)
- $13.80K
- P/E
- —
- EPS
- -0.50
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- ₪3.30
- 52-week low
- ₪0.78
- Avg volume (3M)
- —
- Shares outstanding
- 21.00M
- Employees
- 1
- Next earnings
- —
About Merchavia Holdings and Investments Ltd
Merchavia Holdings and Investments Ltd., founded in 1972 and based in Bnei Brak, Israel, operates as an investment company with a primary focus on the Israeli life sciences industry. Its varied portfolio includes funding and developing numerous cutting-edge medical and healthcare solutions. The company's ventures cover: Innovative diagnostic tools aimed at detecting cancer. Wearable medical equipment, such as smartwatches, bracelets, and patches, equipped with sensor technology for health monitoring and diagnostic purposes. Aura smart air, an intelligent, data-driven system that uses user behavior algorithms and real-time smart sensors to oversee and manage both indoor and outdoor air quality. TrainPain, a digital therapeutic designed to enhance the mental and emotional health of individuals suffering from neuropathic and fibromyalgia pain. RevDx (Revolutionary Diagnostics), a compact, handheld device enabling immediate complete blood count analyses. A rechargeable electric cannabis inhaler, which connects via Bluetooth to the VEOLI App for managing dosages and capsule supply. An artificial intelligence-driven neuromonitoring instrument intended for use in operating rooms to prevent nerve damage during surgery. Additionally, Merchavia is engaged in the creation, manufacturing, and commercialization of women's health products. Notable offerings include Ballerine, a copper-based, hormone-free intrauterine contraceptive device, and a spherical endometrial ablation device currently undergoing Phase IIa clinical trials for treating abnormal uterine bleeding. The company was formerly known as Nepco Star Ltd. until its name officially changed to Merchavia Holdings and Investments Ltd. in November 2014.
- ISIN
- IL0002570146
- Founded
- 1972
- Listed since
- Aug 12, 2002
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.67 | +0.03% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $375.01 | +0.39% |
| Stryker CorporationNYSE: SYK | $125.74B | $327.81 | -0.50% |
| Medtronic plcNYSE: MDT | $118.91B | $92.90 | -0.48% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €160.25 | -0.90% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.11 | +0.20% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €40.06 | -0.82% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.